A Safety and Tolerability Study of ILB® in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT03705390 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
11
Enrollment
OTHER
Sponsor class

Stopped Study initially suspended due to COVID-19 Pandemic- treatment stopped - never reopened to recruitment..

Conditions

Interventions

Sponsor

University of Birmingham

Collaborators